サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：米国の医療用画像診断機器市場：規模、シェア、動向分析（2024-2030年）：MedSuite
市場調査レポート
商品コード
1365524

米国の医療用画像診断機器市場：規模、シェア、動向分析（2024-2030年）：MedSuite

Medical Imaging Device Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: X-Ray Imaging, Breast Imaging, and 5 more
出版日: | 発行: iData Research Inc. | ページ情報: 英文 387 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国の医療用画像診断機器市場：規模、シェア、動向分析（2024-2030年）：MedSuite
出版日: 2023年10月05日
発行: iData Research Inc.
ページ情報: 英文 387 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

2023年、米国の医療用画像診断機器の市場規模は90億米ドルとなりました。今後、2.7%の年間平均成長率（CAGR）で拡大し、予測期間中に109億米ドルに達すると予測されています。

慢性疾患の急増とその影響に対する認識の高まりが、イメージング市場の成長を促す重要な要因となっています。慢性疾患の流行に伴い、正確でタイムリーな診断、継続的な疾患モニタリング、治療効果の評価に対するニーズが高まっています。慢性疾患は一般的にゆっくりと進行するため、効果的な管理には早期発見が重要な役割を果たします。MRI、CTスキャン、超音波検査などの高度な画像診断技術により、ヘルスケア提供者は慢性疾患が重症化する前にその初期徴候を発見することができます。この早期発見がタイムリーな介入を可能にし、最終的には治療結果の改善と患者のQOL向上につながります。

2023年、GE Healthcareは米国の医療用画像診断機器市場のトップランナーとして台頭し、あらゆるイメージング分野で独走態勢を築きました。GEは、X線、超音波、核医学分野を独占しています。

Siemens Healthineersは、磁気共鳴画像装置（MRI）とコンピュータ断層撮影装置（CT）市場で、2023年の画像診断市場全体で2位の座を確保しました。また、X線、乳房画像、超音波、核医学市場にも積極的に参入しました。

Philips Healthcareは、2023年の総合イメージング市場で第3の主要参入企業と位置付けられ、X線、乳房イメージング、MRI、超音波、CT市場など、さまざまな領域で競合しました。

当レポートでは、米国の医療用画像診断機器市場について調査し、市場の概要とともに、セグメント別動向、COVID-19の影響分析、市場促進要因および阻害要因、競合市場シェア分析、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

調査手法

COVID-19が米国の医療用画像診断機器市場に与える影響

  • イントロダクション
  • 市場セグメント別の分析

製品の評価

  • イントロダクション
  • 製品ポートフォリオ
  • 規制問題とリコール
  • 臨床試験

米国の医用画像市場概要

  • イントロダクション
  • 市場概要とトレンド分析
  • 促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 競合市場シェア分析
  • 合併と買収
  • 企業プロファイル
    • Bayer
    • Canon Medical
    • Fujifilm
    • GE Healthcare
    • Hologic
    • Philips Healthcare
    • Siemens Healthineers
  • SWOT分析

手技件数

  • イントロダクション
  • 手技

X線画像市場

乳房画像市場

磁気共鳴画像市場

超音波画像市場

コンピュータ断層撮影画像市場

核医学イメージング市場

造影剤およびインジェクター画像処理市場

略語

図表

LIST OF CHARTS

  • Chart 1 1: Medical Imaging Market by Segment, U.S., 2023 - 2030
  • Chart 1 2: Medical Imaging Market Overview, U.S., 2023 & 2030
  • Chart 2 1: Multi-Scenario U.S. Medical Imaging Market Forecast, U.S., 2020 - 2030 (US$M)
  • Chart 4 1: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023
  • Chart 5 1: U.S. Medical Imaging Procedures by Segment, U.S., 2020 - 2030
  • Chart 6 1: X-ray Imaging Market by Segment, U.S., 2020 - 2030
  • Chart 6 2: Leading Competitors, X-ray Market, U.S., 2023
  • Chart 7 1: Breast Imaging Market by Type, U.S., 2020 - 2030
  • Chart 7 2: Leading Competitors, Breast Imaging Market, U.S., 2023
  • Chart 8 1: MRI Market by Type, U.S., 2020 - 2030
  • Chart 8 2: Leading Competitors, Magnetic Resonance Imaging Market, U.S., 2023
  • Chart 9 1: Ultrasound Market, U.S., 2020 - 2030
  • Chart 9 2: Leading Competitors, Breast Imaging Market, U.S., 2023
  • Chart 10 1: Computed Tomography Imaging Market by Type, U.S., 2020 - 2030
  • Chart 10 2: Leading Competitors, Computed Tomography Market, U.S., 2023
  • Chart 11 1: Nuclear Medicine Imaging Market by Type, U.S., 2020 - 2030
  • Chart 11 2: Leading Competitors, Nuclear Medicine Imaging Market, U.S., 2023
  • Chart 12 1: Contrast Agent and Injector Market by Segment by Type, U.S., 2020 - 2030
  • Chart 12 2: Leading Competitors, Computed Tomography Market, U.S., 2023

LIST OF FIGURES

  • Figure 1 1: Medical Imaging Market Share Ranking by Segment, U.S., 2023 (1 of 2)
  • Figure 1 2: Medical Imaging Market Share Ranking by Segment, U.S., 2023 (2 of 2)
  • Figure 1 3: Companies Researched in This Report
  • Figure 1 4: Factors Impacting the Medical Imaging Market by Segment, U.S. (1 of 2)
  • Figure 1 5: Factors Impacting the Medical Imaging Market by Segment, U.S. (2 of 2)
  • Figure 1 6: Recent Events in the U.S. Medical Imaging Market, U.S., 2019 - 2023 (1 of 2)
  • Figure 1 7: Recent Events in the U.S. Medical Imaging Market, U.S., 2019 - 2023 (2 of 2)
  • Figure 1 8: U.S. Medical Imaging Procedures Covered (1 of 4)
  • Figure 1 9: U.S. Medical Imaging Procedures Covered (2 of 4)
  • Figure 1 10: U.S. Medical Imaging Procedures Covered (3 of 4)
  • Figure 1 11: U.S. Medical Imaging Procedures Covered (4 of 4)
  • Figure 1 12: Procedure Codes Investigated (1 of 3)
  • Figure 1 13: Procedure Codes Investigated (2 of 3)
  • Figure 1 14: Procedure Codes Investigated (3 of 3)
  • Figure 1 15: U.S. Medical Imaging Markets Covered (1 of 3)
  • Figure 1 16: U.S. Medical Imaging Markets Covered (2 of 3)
  • Figure 1 17: U.S. Medical Imaging Markets Covered (3 of 3)
  • Figure 1 18: Key Report Updates
  • Figure 1 19: Version History
  • Figure 2 1: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2 2: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 2 3: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2 4: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 2 5: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 2 6: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 3 1: Analog X-ray Devices by Company
  • Figure 3 2: Computed Radiography X-ray Devices by Company
  • Figure 3 3: Digital Radiography X-ray Devices by Company (1 of 2)
  • Figure 3 4: Digital Radiography X-ray Devices by Company (2 of 2)
  • Figure 3 5: Fluoroscopy Devices by Company (1 of 2)
  • Figure 3 6: Fluoroscopy Devices by Company (2 of 2)
  • Figure 3 7: Cardiovascular X-ray Devices by Company
  • Figure 3 8: Computed Radiography Mammography Devices by Company
  • Figure 3 9: Digital Radiography Mammography Devices by Company
  • Figure 3 10: Digital Breast Tomosynthesis Devices by Company
  • Figure 3 11: Positron Emission Mammography Devices by Company
  • Figure 3 12: Gamma Imaging Devices by Company
  • Figure 3 13: Breast Ultrasound Devices by Company
  • Figure 3 14: MRI Coil Market by Company
  • Figure 3 15: Magnetic Resonance Imaging Market by Company (1 of 2)
  • Figure 3 16: Magnetic Resonance Imaging Market by Company (2 of 2)
  • Figure 3 17: Cardiology Ultrasound Devices by Company
  • Figure 3 18: Radiology Ultrasound Devices by Company
  • Figure 3 19: OB/GYN Ultrasound Devices by Company (1 of 2)
  • Figure 3 20: OB/GYN Ultrasound Devices by Company (2 of 2)
  • Figure 3 21: Urology Ultrasound Devices by Company
  • Figure 3 22: Surgery Ultrasound Devices by Company
  • Figure 3 23: Vascular Ultrasound Devices by Company
  • Figure 3 24: Ophthalmic Ultrasound Devices by Company
  • Figure 3 25: Point-of-Care Ultrasound Imaging Devices by Company
  • Figure 3 26: Computed Tomography Imaging Market by Company
  • Figure 3 27: PET/CT Devices by Company
  • Figure 3 28: SPECT Devices by Company
  • Figure 3 29: SPECT/CT Devices by Company
  • Figure 3 30: 1.2.7 X-ray and CT Contrast Agent and Injector by Company
  • Figure 3 31: MRI Contrast Agent and Injector by Company
  • Figure 3 32: Ultrasound Contrast Agent and Injector by Company
  • Figure 3 33: Contrast Injector by Company
  • Figure 3 34: Class 2 Device Recall Philips Allura Xper, Allura Centron, Allura CV, Azurion, UNIQ Clarity, and MultiDiagnostEleva System
  • Figure 3 35: Class 2 Device Recall DigitalDiagnost C90
  • Figure 3 36: Class 2 Device Recall Philips
  • Figure 3 37: Class 2 Device Recall FDR AQRO (DRXD 1000)
  • Figure 3 38: Class 2 Device Recall Luminos Agile Max
  • Figure 3 39: Class 2 Device Recall Luminos dRF Max, Luminos Agile Max, Uroskop Omnia Max, Multitom Rax
  • Figure 3 40: Class 2 Device Recall DigitalDiagnost C50
  • Figure 3 41: Class 2 Device Recall DigitalDiagnost C90
  • Figure 3 42: Class 2 Device Recall DigitalDiagnost
  • Figure 3 43: Class 2 Device Recall ProxiDiagnost N90
  • Figure 3 44: Class 2 Device Recall Omnera
  • Figure 3 45: Class 2 Device Recall Interventional Fluoroscopic Xray System
  • Figure 3 46: Class 2 Device Recall DR 800 with MUSICA Dynamic
  • Figure 3 47: Class 2 Device Recall Agfa DR 800
  • Figure 3 48: Class 2 Device Recall Ysio Max
  • Figure 3 49: Class 2 Device Recall Ysio Max
  • Figure 3 50: Class 2 Device Recall Cardio Vascular Allura Centron Interventional Fluoroscopic Xray System
  • Figure 3 51: Class 2 Device Recall Fujifilm FDR Go Plus Mobile Xray System
  • Figure 3 52: Class 2 Device Recall AGFA Digital Radiography X Ray System DR 800
  • Figure 3 53: Class 2 Device Recall Hologic
  • Figure 3 54: Class 2 Device Recall EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EP
  • Figure 3 55: Class 2 Device Recall Philips EPIQ Diagnostic Ultrasound System
  • Figure 3 56: Class 2 Device Recall MAMMOMAT Revelation
  • Figure 3 57: Class 2 Device Recall Selenia Dimensions Mammography System
  • Figure 3 58: Class 2 Device Recall MAMMOMAT Revelation
  • Figure 3 59: Class 2 Device Recall GE Senographe Pristina
  • Figure 3 60: Class 2 Device Recall Philips Ingenia Elition S
  • Figure 3 61: Class 2 Device Recall Philips Ingenia Elition X
  • Figure 3 62: Class 2 Device Recall SIGNA Premier
  • Figure 3 63: Class 2 Device Recall GE Healthcare MR Systems.
  • Figure 3 64: Class 2 Device Recall Signa 1.5T TwinSpeed
  • Figure 3 65: Class 2 Device Recall 1.5T SIGNA Excite HD, 3.0T SIGNA Excite HD
  • Figure 3 66: Class 2 Device Recall SIGNA Excite 3T
  • Figure 3 67: Class 2 Device Recall 1.5T and 3.0T SIGNA HDx, 1.5T and 3.0T SIGNA HDxt, and 1.5T SIGNA HDxt Mobile
  • Figure 3 68: Class 2 Device Recall SIGNA Architect
  • Figure 3 69: Class 2 Device Recall SIGNA Artist
  • Figure 3 70: Class 2 Device Recall SIGNA Creator, SIGNA Explorer
  • Figure 3 71: Class 2 Device Recall SIGNA Voyager
  • Figure 3 72: Class 2 Device Recall SIGNA Pioneer
  • Figure 3 73: Class 2 Device Recall SIGNA Premier
  • Figure 3 74: Class 2 Device Recall SIGNA Premier
  • Figure 3 75: Class 2 Device Recall SIGNA Artist
  • Figure 3 76: Class 2 Device Recall SIGNA Architect
  • Figure 3 77: Class 2 Device Recall SIGNA Pioneer
  • Figure 3 78: Class 2 Device Recall SIGNA Voyager
  • Figure 3 79: Class 2 Device Recall SIGNA Creator, SIGNA Explorer
  • Figure 3 80: Class 2 Device Recall SIGNA MR355, SIGNA MR360
  • Figure 3 81: Class 2 Device Recall Vantage Galan 3T
  • Figure 3 82: Class 2 Device Recall ACUSON Redwood Systems with Software Version 2.0
  • Figure 3 83: Class 2 Device Recall GE Healthcare Vivid
  • Figure 3 84: Class 2 Device Recall NovaGuide Intelligent Ultrasound System
  • Figure 3 85: Class 2 Device Recall Vivid S5
  • Figure 3 86: Class 2 Device Recall Vivid S5 N
  • Figure 3 87: Class 2 Device Recall Vivid S6
  • Figure 3 88: Class 2 Device Recall Vivid S6 N
  • Figure 3 89: Class 2 Device Recall Vivid q
  • Figure 3 90: Class 2 Device Recall Vivid q N
  • Figure 3 91: Class 2 Device Recall Vivid i
  • Figure 3 92: Class 2 Device Recall Vivid i N
  • Figure 3 93: Class 2 Device Recall Canon Aplio Ultrasound System
  • Figure 3 94: Class 2 Device Recall ACUSON Juniper Diagnostic Ultrasound System
  • Figure 3 95: Class 2 Device Recall ACUSON Sequoia Ultrasound Imaging System
  • Figure 3 96: Class 2 Device Recall Fujifilm
  • Figure 3 97: Class 2 Device Recall EPIQ CVxi Diagnostic Ultrasound Systems
  • Figure 3 98: Class 2 Device Recall Philips EPIQ Diagnostic Ultrasound Systems
  • Figure 3 99: Class 2 Device Recall Philips Afiniti Diagnostic Ultrasound Systems
  • Figure 3 100: Class 2 Device Recall EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EP
  • Figure 3 101: Class 2 Device Recall ACUSON Juniper ultrasound imaging system
  • Figure 3 102: Class 2 Device Recall Philips Incisive CT
  • Figure 3 103: Class 2 Device Recall Philips
  • Figure 3 104: Class 2 Device Recall Spectral CT 7500
  • Figure 3 105: Class 2 Device Recall Incisive CT
  • Figure 3 106: Class 2 Device Recall SOMATOM Confidence
  • Figure 3 107: Class 2 Device Recall SOMATOM Edge Plus
  • Figure 3 108: Class 2 Device Recall SOMATOM Definition AS
  • Figure 3 109: Class 2 Device Recall SOMATOM Definition Edge
  • Figure 3 110: Class 2 Device Recall Siemens
  • Figure 3 111: Class 2 Device Recall Revolution CT, Revolution CT ES, Revolution Apex, Revolution CT with Apex Edition
  • Figure 3 112: Class 2 Device Recall Philips
  • Figure 3 113: Class 2 Device Recall Revolution CT with Apex Edition CT System
  • Figure 3 114: Class 2 Device Recall Biograph mCT, Biograph Horizon, Biograph Vision
  • Figure 3 115: Class 2 Device Recall Symbia
  • Figure 3 116: Class 2 Device Recall GE NM/CT 850
  • Figure 3 117: Class 2 Device Recall GE NM/CT 860
  • Figure 3 118: Class 2 Device Recall Optima NM/CT 640
  • Figure 3 119: Class 2 Device Recall MEDRAD Stellant FLEX Syringe Kits
  • Figure 3 120: Optimization of Bedside Chest X-rays Taken in the Intensive Care Unit by Using Current Software-Based Techniques
  • Figure 3 121: Identify Coronavirus Disease by Chest X-ray
  • Figure 3 122: Next Generation X-ray Imaging System
  • Figure 3 123: Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab
  • Figure 3 124: Chest X-ray in Diagnosis of Heart Failure
  • Figure 3 125: Comparison of Breast Cancer Screening with CESM to DBT in Women with Dense Breasts (CMIST)
  • Figure 3 126: Preoperative Magnetic Resonance Imaging to Obtain Adequate Resection Margins in Breast Conserving Surgery, (PRIMAR) Trial
  • Figure 3 127: Novel Thermal Imaging Technique for Breast Screening
  • Figure 3 128: An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
  • Figure 3 129: Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
  • Figure 3 130: Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis (AMELIA)
  • Figure 3 131: Discomfort Assessment of Senographe Pristina Patient-assisted Versus Standard Compression Mode and Quality Assessment of Screening Mammograms
  • Figure 3 132: Breast Density Measurements in Digital Mammography and Breast Tomosynthesis Systems of Different Pixel Size
  • Figure 3 133: Simulated Screening Study for Breast Imaging
  • Figure 3 134: Molecular Breast Imaging in Screening Breast Cancer
  • Figure 3 135: Evaluation of New Magnetic Resonance Techniques
  • Figure 3 136: New Heart Imaging Techniques to Evaluate Possible Heart Disease
  • Figure 3 137: Magnetic Resonance Imaging of Breast Cancer
  • Figure 3 138: Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
  • Figure 3 139: MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases
  • Figure 3 140: Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
  • Figure 3 141: A Percutaneous Ultrasound Device with Needle Guide for Vascular Access
  • Figure 3 142: 3D Ultrasound Breast Imaging
  • Figure 3 143: Ultrasound Imaging of Kidney Stones and Lithotripsy
  • Figure 3 144: Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones
  • Figure 3 145: Point of Care Ultrasound in Obstetric Triage (POCUS)
  • Figure 3 146: Point-of-Care Ultrasound in Primary Care (POCUS iGP 1)
  • Figure 3 147: Use of POC Pocket Ultrasound in the Estimation of Left and Right Atrial Pressures
  • Figure 3 148: Point of Care Ultrasonography
  • Figure 3 149: Prospective Evaluation of Myocardial Perfusion Computed Tomography Trial (PERFUSERCT)
  • Figure 3 150: Computed Tomography vs. Endoscopy Study
  • Figure 3 151: Computed Tomography Scanning in ICU
  • Figure 3 152: Evaluating New Radiation Techniques for Cardiovascular Imaging
  • Figure 3 153: 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assessment for Left Sided Breast Cancers Radiotherapy
  • Figure 3 154: Spectral CT Clinical Trial Protocol
  • Figure 3 155: Computed Tomography for COVID-19 Diagnosis
  • Figure 3 156: Fluorocholine PET/CT Basket Trial
  • Figure 3 157: SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
  • Figure 3 158: SPECT/CT for the Characterization of Renal Masses
  • Figure 3 159: Gated and Non-Gated Dynamic PET/CT Imaging
  • Figure 3 160: Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System
  • Figure 3 161: Evaluation of a New Generation of PET-CT OMNI
  • Figure 3 162: Demonstration of a Next Generation PET CT System
  • Figure 3 163: Standard PET/CT vs. Digital PET/CT
  • Figure 3 164: Radio-opaque Contrast Agents for Liver Cancer Targeting with KIM During Radiation Therapy (ROCK-RT)
  • Figure 3 165: Dotarem vs Gadobutrol Contrast for Breast MRI
  • Figure 3 166: Chest CT Using Low-Concentration Iodine Contrast Media
  • Figure 3 167: A Study Called GUS to Understand How Much of the Contrast Agent Gadavist Is Used and How Much Is Wasted in Two Different Containers (Single-Dose Vials and Imaging Bulk Packages) in a Real-World Setting
  • Figure 3 168: Negative Oral Contrast Agents Utilization in PET/CT Studies
  • Figure 4 1: U.S. Medical Imaging Market by Segment, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 4 2: U.S. Medical Imaging Market by Segment, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 4 3: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023 (1 of 2)
  • Figure 4 4: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023 (2 of 2)
  • Figure 4 5: SWOT Analysis, Bayer
  • Figure 4 6: SWOT Analysis, Canon Medical
  • Figure 4 7: SWOT Analysis, Fujifilm
  • Figure 4 8: SWOT Analysis, Hologic
  • Figure 5 1: Procedure Codes Investigated (1 of 3)
  • Figure 5 2: Procedure Codes Investigated (2 of 3)
  • Figure 5 3: Procedure Codes Investigated (3 of 3)
  • Figure 5 4: U.S. Medical Imaging Procedures by Segment, U.S., 2020 - 2030
  • Figure 5 5: X-ray Procedures by Segment, U.S., 2020 - 2030
  • Figure 5 6: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (1 of 4)
  • Figure 5 7: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (2 of 4)
  • Figure 5 8: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (3 of 4)
  • Figure 5 9: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (4 of 4)
  • Figure 5 10: Fluoroscopy X-ray Procedures by Type, U.S., 2020 - 2030
  • Figure 5 11: Cardiovascular X-ray Procedures by Anatomy, U.S., 2020 - 2030
  • Figure 5 12: Breast Imaging Procedures by Modality, U.S., 2020 - 2030
  • Figure 5 13: Magnetic Resonance Imaging Procedures by Modality, U.S., 2020 - 2030
  • Figure 5 14: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (1 of 3)
  • Figure 5 15: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (2 of 3)
  • Figure 5 16: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (3 of 3)
  • Figure 5 17: Magnetic Resonance Angiography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
  • Figure 5 18: Magnetic Resonance Angiography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
  • Figure 5 19: Guidance Magnetic Resonance Imaging Procedures, U.S., 2020 - 2030
  • Figure 5 20: Intraoperative Magnetic Resonance Imaging Procedures, U.S., 2020 - 2030
  • Figure 5 21: Ultrasound Procedures by Type, U.S., 2020 - 2030
  • Figure 5 22: Ultrasound Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
  • Figure 5 23: Ultrasound Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
  • Figure 5 24: Cardiac Ultrasound Procedures, U.S. by Type, 2020 - 2030
  • Figure 5 25: Ultrasound Guidance Procedures, U.S., 2020 - 2030
  • Figure 5 26: Computed Tomography Procedures by Type, U.S., 2020 - 2030
  • Figure 5 27: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 3)
  • Figure 5 28: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 3)
  • Figure 5 29: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (3 of 3)
  • Figure 5 30: Computed Tomography Angiography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
  • Figure 5 31: Computed Tomography Angiography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
  • Figure 5 32: Computed Tomography Guidance Procedures, U.S., 2020 - 2030
  • Figure 5 33: Nuclear Medicine Procedures by Modality, U.S., 2020 - 2030
  • Figure 5 34: SPECT Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
  • Figure 5 35: SPECT Procedures by Modality, U.S., 2020 - 2030 (2 of 2)
  • Figure 5 36: PET Procedures by Anatomy, U.S., 2020 - 2030
  • Figure 6 1: X-ray Imaging Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 6 2: Total X-ray Market, U.S., 2020 - 2030
  • Figure 6 3: Analog X-ray Market, U.S., 2020 - 2030
  • Figure 6 4: Computed Radiography X-ray Market, U.S., 2020 - 2030
  • Figure 6 5: Digital Radiography X-ray Market, U.S., 2020 - 2030
  • Figure 6 6: Fluoroscopy Radiography X-ray Market, U.S., 2020 - 2030
  • Figure 6 7: Cardiovascular X-ray Market, U.S., 2020 - 2030
  • Figure 6 8: Leading Competitors, X-ray Market, U.S., 2023
  • Figure 7 1: Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 7 2: Mammography Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7 3: Computed Radiography Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 7 4: Digital Radiography Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 5: Digital Tomosynthesis Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 6: Molecular Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 7 7: Total Molecular Breast Imaging Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 8: Positron Emission Mammography Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 9: Gamma Imaging Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 10: Ultrasound Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 7 11: Total Breast Ultrasound, U.S., 2020 - 2030
  • Figure 7 12: Manual Breast Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 13: Automated Breast Ultrasound Market, U.S., 2020 - 2030 (US$M)
  • Figure 7 14: MRI Coil Market, U.S., 2020 - 2030
  • Figure 7 15: Leading Competitors, Breast Imaging Market, U.S., 2023
  • Figure 8 1: MRI Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 8 2: Total Closed-Bore MRI Market by Segment, 2020 - 2030 (US$M)
  • Figure 8 3: Low-Field Closed-Bore MRI Market, U.S., 2020 - 2030
  • Figure 8 4: Mid-Field Closed-bore MRI Market, U.S., 2020 - 2030
  • Figure 8 5: High-Field Closed-Bore MRI Market, U.S., 2020 - 2030
  • Figure 8 6: Total Wide-Bore MRI Market by Segment, 2020 - 2030 (US$M)
  • Figure 8 7: Low-Field Wide-Bore MRI Market, U.S., 2020 - 2030
  • Figure 8 8: Mid-Field Wide-Bore MRI Market, U.S., 2020 - 2030
  • Figure 8 9: High-Field Wide-Bore MRI Market, U.S., 2020 - 2030
  • Figure 8 10: Leading Competitors, Magnetic Resonance Imaging Market, U.S., 2023
  • Figure 9 1: Ultrasound Market by Type, U.S., 2020 - 2030 (US$M) (1 of 2)
  • Figure 9 2: Ultrasound Market by Type, U.S., 2020 - 2030 (US$M) (2 of 2)
  • Figure 9 3: Total Ultrasound Imaging Market, U.S., 2020 - 2030
  • Figure 9 4: Cardiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 5 High-End Cardiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 6 Hand Carried Cardiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 7 Hospital Cardiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 8 Office Cardiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 9: Radiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 10 High-End Radiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 11 Hand Carried Radiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 12 Hospital Radiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 13 Office Radiology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 14: Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 15 High-End Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 16 Hand Carried Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 17 Hospital Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 18 Office Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 19: Urology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 20 High-End Urology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 21 Hand Carried Urology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 22 Hospital Urology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 23 Office Urology Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 24: Surgery Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 25: Vascular Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 26: Ophthalmic Ultrasound Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9 27: Total Ophthalmic Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 28: Pachymeter Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 29: A-Scan Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 30: B-Scan Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 31: A/B Scan Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 32: Ultrasound Biomicroscope Market, U.S., 2020 - 2030
  • Figure 9 33: Point-of-Care Ultrasound Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 9 34: Total Point-of-Care Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 35: Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 36 Hand Carried Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 37 Cart-Based Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 38: Total Anesthesia Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 39 Hand-Carried Anesthesia Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 40 Cart-Based Anesthesia Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 41 Regional Anesthesia Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 42 General Anesthesia Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 43: Critical Care Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 44 Hand-Carried Critical Care Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 45 Cart-Based Critical Care Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 46: Musculoskeletal Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 47: Other Point-of-Care Ultrasound Market, U.S., 2020 - 2030
  • Figure 9 48: Leading Competitors, Ultrasound Imaging Market, U.S., 2023 (1 of 2)
  • Figure 9 49: Leading Competitors, Ultrasound Imaging Market, U.S., 2023 (2 of 2)
  • Figure 10 1: Computed Tomography Imaging Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 10 2: Total Computed Tomography Imaging Market, U.S., 2020 - 2030
  • Figure 10 3: 16/20 Slice Market, U.S., 2020 - 2030
  • Figure 10 4: 32/40 Slice Market, U.S., 2020 - 2030
  • Figure 10 5: 64 Slice Market, U.S., 2020 - 2030
  • Figure 10 6: Ultra-Premium Slice Market, U.S., 2020 - 2030
  • Figure 10 7: Leading Competitors, Computed Tomography Imaging Market, U.S., 2023
  • Figure 11 1: Nuclear Medicine Imaging Market by Type, U.S., 2020 - 2030 (US$M)
  • Figure 11 2: PET/CT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
  • Figure 11 3: SPECT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
  • Figure 11 4: SPECT/CT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
  • Figure 11 5: Leading Competitors, Nuclear Medicine Imaging Market, U.S., 2023
  • Figure 12 1: Contrast Agent and Injector Market by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 12 2: Total Contrast Agents by Segment, U.S., 2020 - 2030 (US$M)
  • Figure 12 3: X-ray/CT Contrast Agent Market, U.S., 2020 - 2030
  • Figure 12 4: MRI Contrast Agent Market, U.S., 2020 - 2030
  • Figure 12 5: Ultrasound Contrast Agent Market, U.S., 2020 - 2030
  • Figure 12 6: Contrast Injector Market, U.S., 2020 - 2030
  • Figure 12 7: Leading Competitors, Computed Tomography Imaging Market, U.S., 2023
目次
Product Code: iDATA_USIMG24

In 2023, the U.S. medical imaging market achieved a valuation of $9.0 billion, with a projected growth rate of 2.7% at a Compound Annual Growth Rate (CAGR), the market is anticipated to reach $10.9 billion during the forecast period.

Our comprehensive report suite on the U.S. Medical Imaging Market encompasses a diverse spectrum of over 60 companies in the United States. It encompasses X-ray imaging, breast imaging, magnetic resonance imaging (MRI), ultrasound equipment, computed tomography (CT) imaging, nuclear medicine imaging, and contrast agents and injectors.

MARKET REPORT DATA TYPES INCLUDED:

  • Unit Sales, Procedure Numbers, Average Selling Prices, Market Size & Growth Trends
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2030, and Historical Data to 2020
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. Medical Imaging Market Insights

The surge in chronic diseases and the increased recognition of their consequences serve as significant drivers fueling the growth of the imaging market. As chronic illnesses become more prevalent, there is an increasing need for accurate and timely diagnosis, ongoing disease monitoring, and the evaluation of treatment effectiveness. Chronic conditions typically develop slowly, underscoring the crucial role of early detection in effective management. Advanced imaging technologies such as MRI, CT scans, and ultrasound empower healthcare providers to identify the initial signs of chronic diseases before they advance to more severe stages. This early identification enables timely intervention, ultimately leading to improved treatment outcomes and an enhanced quality of life for patients.

U.S. Medical Imaging Market Share Insights

In 2023, GE Healthcare emerged as the frontrunner in the U.S. imaging market, holding a unique position as the sole contender in every imaging segment. GE dominated the X-ray, ultrasound, and nuclear medicine sectors.

Securing the second spot in the overall imaging market for 2023, Siemens Healthineers excelled in the magnetic resonance imaging (MRI) and computed tomography (CT) markets. The company also actively participated in the X-ray, breast imaging, ultrasound, and nuclear medicine markets.

Philips Healthcare, positioned as the third major player in the comprehensive imaging market in 2023, competed across various domains, including X-ray, breast imaging, MRI, ultrasound, and CT markets.

MARKET SEGMENTATION SUMMARY

X-Ray Imaging Market - includes analog, computed radiography (CR), digital radiography (DR), fluoroscopy and cardiovascular X-ray systems.

Breast Imaging Market - includes mammography, molecular breast imaging (MBI), breast ultrasound and breast magnetic resonance imaging (MRI) coil markets.

Magnetic Resonance Imaging Market - includes low-, mid- and high-field MRI systems as well as closed-bore and wide-bore MRIs of any field strength.

Ultrasound Imaging Market - segmented into: equipment for cardiology, radiology, obstetrics and gynecology (OB/GYN), urology, surgery, vascular, ophthalmic and point of care (POC).

Computed Tomography Imaging Market - includes 16/20, 32/40, 64 and ultra-premium slice scanners.

Nuclear Medicine Imaging Market - includes positron emission tomography/computed tomography (PET/CT), single photon emission computed tomography (SPECT) and single photon emission computed tomography/computed tomography (SPECT/CT).

Contrast Agent and Injector Imaging Market - includes X-ray and computed tomography (CT) agents, magnetic resonance imaging (MRI) agents and ultrasound agents as well as contrast injectors.

Research Scope Summary

Report Attribute

  • Regions: United States
  • Base Year: 2023
  • Forecast: 2024-2030
  • Historical Data: 2020-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • U.S. MEDICAL IMAGING DEVICE MARKET OVERVIEW
  • COMPETITIVE ANALYSIS
  • MARKET TRENDS
  • MARKET DEVELOPMENTS
  • PROCEDURES INCLUDED
  • PROCEDURE CODES INVESTIGATED
  • MARKETS INCLUDED
  • KEY REPORT UPDATES
  • VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE U.S. MEDICAL IMAGING MARKET

  • 2.1. INTRODUCTION
  • 2.2. ANALYSIS BY MARKET SEGMENT
    • 2.2.1. Worst Case Scenario
    • 2.2.2. Base Case Scenario
    • 2.2.3. Best Case Scenario

PRODUCT ASSESSMENT

  • 3.1. INTRODUCTION
  • 3.2. PRODUCT PORTFOLIOS
    • 3.2.1. X-ray Imaging Market
      • 3.2.1.1. Analog X-ray Devices
      • 3.2.1.2. Computed Radiography X-ray Devices
      • 3.2.1.3. Digital Radiography X-ray Devices
      • 3.2.1.4. Fluoroscopy Devices
      • 3.2.1.5. Cardiovascular X-ray Devices
    • 3.2.2. Breast Imaging Market
      • 3.2.2.1. Mammography
      • 3.2.2.1.1. Computed Radiography Mammography Devices
      • 3.2.2.1.2. Digital Radiography Mammography Devices
      • 3.2.2.1.3. Digital Breast Tomosynthesis Devices
      • 3.2.2.2. Molecular Breast Imaging
      • 3.2.2.2.1. Positron Emission Mammography Devices
      • 3.2.2.2.2. Gamma Imaging Devices
      • 3.2.2.3. Breast Ultrasound
      • 3.2.2.4. MRI Coil Market
    • 3.2.3. Magnetic Resonance Imaging Market
      • 3.2.3.1. Closed-Bore vs. Wide-Bore Systems
    • 3.2.4. Ultrasound Imaging Market
      • 3.2.4.1. Cardiology Ultrasound Devices
      • 3.2.4.2. Radiology Ultrasound Devices
      • 3.2.4.3. OB/GYN Ultrasound Devices
      • 3.2.4.4. Urology Ultrasound Devices
      • 3.2.4.5. Surgery Ultrasound Devices
      • 3.2.4.6. Vascular Ultrasound Devices
      • 3.2.4.7. Ophthalmic Ultrasound Devices
      • 3.2.4.8. Point-of-Care Ultrasound Imaging Devices
    • 3.2.5. Computed Tomography Imaging Market
    • 3.2.6. Nuclear Medicine Imaging Market
      • 3.2.6.1. PET/CT
      • 3.2.6.2. SPECT
      • 3.2.6.3. SPECT/CT Devices
    • 3.2.7. Contrast Agent and Injector Market
      • 3.2.7.1. X-ray and CT
      • 3.2.7.2. MRI
      • 3.2.7.3. Ultrasound
      • 3.2.7.4. Contrast Injector
  • 3.3. REGULATORY ISSUES AND RECALLS
    • 3.3.1. X-ray Imaging Market FDA Recalls
    • 3.3.2. Breast Imaging Market FDA Recalls
    • 3.3.3. Magnetic Resonance Imaging Market FDA Recalls
    • 3.3.4. Ultrasound Imaging Market FDA Recalls
    • 3.3.5. Computed Tomography Imaging Market FDA Recalls
    • 3.3.6. Nuclear Medicine Imaging Market FDA Recalls
    • 3.3.7. Contrast Agent and Injector Market FDA Recalls
  • 3.4. CLINICAL TRIALS
    • 3.4.1. X-ray Imaging Market Clinical Trials
    • 3.4.2. Breast Imaging Market Clinical Trials
    • 3.4.3. Magnetic Resonance Imaging Market Clinical Trials
    • 3.4.4. Ultrasound Imaging Market Clinical Trials
    • 3.4.5. Computed Tomography Imaging Market Clinical Trials
    • 3.4.6. Nuclear Medicine Imaging Market Clinical Trials
    • 3.4.7. Contrast Agent and Injector Market Clinical Trials

U.S. MEDICAL IMAGING MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. MARKET OVERVIEW & TREND ANALYSIS
  • 4.3. DRIVERS AND LIMITERS
    • 4.3.1. Market Drivers
    • 4.3.2. Market Limiters
  • 4.4. COMPETITIVE MARKET SHARE ANALYSIS
  • 4.5. MERGERS AND ACQUISITIONS
  • 4.6. COMPANY PROFILES
    • 4.6.1. Bayer
    • 4.6.2. Canon Medical
    • 4.6.3. Fujifilm
    • 4.6.4. GE Healthcare
    • 4.6.5. Hologic
    • 4.6.6. Philips Healthcare
    • 4.6.7. Siemens Healthineers
  • 4.7. SWOT ANALYSIS
    • 4.7.1. Bayer
    • 4.7.2. Canon Medical
    • 4.7.3. Fujifilm
    • 4.7.4. GE Healthcare
    • 4.7.5. Hologic
    • 4.7.6. Philips Healthcare
    • 4.7.7. Siemens Healthineers

PROCEDURE NUMBERS

  • 5.1. INTRODUCTION
  • 5.2. PROCEDURES
    • 5.2.1. X-ray Procedures
      • 5.2.1.1. Diagnostic X-ray Procedures by Anatomy
      • 5.2.1.2. Fluoroscopy Procedures by Type
      • 5.2.1.3. Cardiovascular X-ray Procedures by Type
    • 5.2.2. Breast Imaging Procedures
    • 5.2.3. Magnetic Resonance Imaging Procedures
      • 5.2.3.1. Diagnostic Magnetic Resonance Imaging Procedures
      • 5.2.3.2. Magnetic Resonance Angiography Procedures
      • 5.2.3.3. Guidance Magnetic Resonance Imaging Procedures
      • 5.2.3.4. Intraoperative Magnetic Resonance Imaging Procedures
    • 5.2.4. Ultrasound Procedures
      • 5.2.4.1. Ultrasound Procedures
      • 5.2.4.1.1. Cardiac Ultrasound Procedures by Type
      • 5.2.4.2. Ultrasound Guidance Procedures
    • 5.2.5. Computed Tomography Procedures
      • 5.2.5.1. Diagnostic Computed Tomography Procedures by Anatomy
      • 5.2.5.2. Computed Tomography Angiography Procedures
      • 5.2.5.3. Computed Tomography Guidance Procedures
    • 5.2.6. Nuclear Medicine Procedures
      • 5.2.6.1. SPECT Procedures by Anatomy
      • 5.2.6.2. PET Procedures by Anatomy

X-RAY IMAGING MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total X-ray Market
    • 6.3.2. Analog X-ray Market
    • 6.3.3. Computed Radiography X-ray Market
    • 6.3.4. Digital Radiography X-ray Market
    • 6.3.5. Fluoroscopy X-ray Market
    • 6.3.6. Cardiovascular X-ray Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE MARKET SHARE ANALYSIS

BREAST IMAGING MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Total Mammography Market
      • 7.3.1.1. Computed Radiography Market
      • 7.3.1.2. Digital Radiography Market
      • 7.3.1.3. Digital Tomosynthesis Market
    • 7.3.2. Total Molecular Breast Imaging Market
      • 7.3.2.1. Positron Emission Mammography Market
      • 7.3.2.2. Gamma Imaging Market
    • 7.3.3. Total Breast Ultrasound Market
      • 7.3.3.1. Manual Breast Ultrasound Market
      • 7.3.3.2. Automated Breast Ultrasound Market
    • 7.3.4. MRI Coil Market
  • 7.4. DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE MARKET SHARE ANALYSIS

MAGNETIC RESONANCE IMAGING MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET OVERVIEW
  • 8.3. MARKET ANALYSIS AND FORECAST
    • 8.3.1. Total Closed-Bore MRI Market
      • 8.3.1.1. Low-Field Closed-Bore MRI Market
      • 8.3.1.2. Mid-Field Closed-Bore MRI Market
      • 8.3.1.3. High-Field Closed-Bore MRI Market
    • 8.3.2. Total Wide-Bore MRI Market
      • 8.3.2.1. Low-Field Wide-Bore MRI Market
      • 8.3.2.2. Mid-Field Wide-Bore MRI Market
      • 8.3.2.3. High-Field Wide-Bore MRI Market
  • 8.4. DRIVERS AND LIMITERS
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. COMPETITIVE MARKET SHARE ANALYSIS

ULTRASOUND IMAGING MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Total Ultrasound Imaging Market
    • 9.3.2. Cardiology Ultrasound Market
      • 9.3.2.1. Cardiology Ultrasound Market by Type
      • 9.3.2.1.1. High-End Cardiology Ultrasound Market
      • 9.3.2.1.2. Hand-Carried Cardiology Ultrasound Market
      • 9.3.2.2. Cardiology Ultrasound Market by Setting
      • 9.3.2.2.1. Hospital Cardiology Ultrasound Market
      • 9.3.2.2.2. Office Cardiology Ultrasound Market
    • 9.3.3. Radiology Ultrasound Market
      • 9.3.3.1. Radiology Ultrasound Market by Type
      • 9.3.3.1.1. High-End Radiology Ultrasound Market
      • 9.3.3.1.2. Hand-Carried Radiology Ultrasound Market
      • 9.3.3.2. Radiology Ultrasound Market by Setting
      • 9.3.3.2.1. Hospital Radiology Ultrasound Market
      • 9.3.3.2.2. Office Radiology Ultrasound Market
    • 9.3.4. Obstetrics and Gynecology Ultrasound Market
      • 9.3.4.1. Obstetrics and Gynecology Ultrasound Market by Type
      • 9.3.4.1.1. High-End Obstetrics and Gynecology Ultrasound Market
      • 9.3.4.1.2. Hand-Carried Obstetrics and Gynecology Ultrasound Market
      • 9.3.4.2. Obstetrics and Gynecology Ultrasound Market by Setting
      • 9.3.4.2.1. Hospital Obstetrics and Gynecology Ultrasound Market
      • 9.3.4.2.2. Office Obstetrics and Gynecology Ultrasound Market
    • 9.3.5. Urology Ultrasound Market
      • 9.3.5.1. Urology Ultrasound Market by Type
      • 9.3.5.1.1. High-End Urology Ultrasound Market
      • 9.3.5.1.2. Hand-Carried Urology Ultrasound Market
      • 9.3.5.2. Urology Ultrasound Market by Setting
      • 9.3.5.2.1. Hospital Urology Ultrasound Market
      • 9.3.5.2.2. Office Urology Ultrasound Market
    • 9.3.6. Surgery Ultrasound Market
    • 9.3.7. Vascular Ultrasound Market
    • 9.3.8. Ophthalmic Ultrasound Market
      • 9.3.8.1. Pachymeter Ophthalmic Ultrasound Market
      • 9.3.8.2. A-Scan Ultrasound Market
      • 9.3.8.3. B-Scan Ultrasound Market
      • 9.3.8.4. A/B Scan Ultrasound Market
      • 9.3.8.5. Ultrasound Biomicroscope Market
    • 9.3.9. Point-of-Care Ultrasound Market
      • 9.3.9.1. Emergency Medicine Point-of-Care Ultrasound Imaging
      • 9.3.9.1.1. Emergency Medicine Point-of-Care Ultrasound by Device Type
      • 9.3.9.2. Total Anesthesia Ultrasound Market
      • 9.3.9.2.1. Anesthesia Ultrasound Equipment Market by Type
      • 9.3.9.2.2. Anesthesia Ultrasound Equipment Market by Function
      • 9.3.9.3. Critical Care Ultrasound Market
      • 9.3.9.3.1. Critical Care Ultrasound Market by Type
      • 9.3.9.4. Musculoskeletal Ultrasound Market
      • 9.3.9.5. Other Point-of-Care Ultrasound Market
  • 9.4. DRIVERS AND LIMITERS
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. COMPETITIVE MARKET SHARE ANALYSIS

COMPUTED TOMOGRAPHY IMAGING MARKET

  • 10.1. INTRODUCTION
  • 10.2. MARKET OVERVIEW
  • 10.3. MARKET ANALYSIS AND FORECAST
    • 10.3.1. Total Computed Tomography Imaging Market
    • 10.3.2. 16/20 Slice Market
    • 10.3.3. 32/40 Slice Market
    • 10.3.4. 64 Slice Market
    • 10.3.5. Ultra-Premium Slice Market
  • 10.4. DRIVERS AND LIMITERS
    • 10.4.1. Market Drivers
    • 10.4.2. Market Limiters
  • 10.5. COMPETITIVE MARKET SHARE ANALYSIS

NUCLEAR MEDICINE IMAGING MARKET

  • 11.1. INTRODUCTION
  • 11.2. MARKET OVERVIEW
  • 11.3. MARKET ANALYSIS AND FORECAST
    • 11.3.1. PET/CT Nuclear Medicine Imaging Market
    • 11.3.2. SPECT Nuclear Medicine Imaging Market
    • 11.3.3. SPECT/CT Nuclear Medicine Imaging Market
  • 11.4. DRIVERS AND LIMITERS
    • 11.4.1. Market Drivers
    • 11.4.2. Market Limiters
  • 11.5. COMPETITIVE MARKET SHARE ANALYSIS

CONTRAST AGENT AND INJECTOR IMAGING MARKET

  • 12.1. INTRODUCTION
  • 12.2. MARKET OVERVIEW
  • 12.3. MARKET ANALYSIS AND FORECAST
    • 12.3.1. Total Contrast Agent Market
      • 12.3.1.1. X-ray/CT Contrast Agent Market
      • 12.3.1.2. MRI Contrast Agent Market
      • 12.3.1.3. Ultrasound Contrast Agent Market
    • 12.3.2. Contrast Injector Market
  • 12.4. DRIVERS AND LIMITERS
    • 12.4.1. Market Drivers
    • 12.4.2. Market Limiters
  • 12.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS